On Tuesday, April 14, 2026, the Board of Directors of Johnson & Johnson (NYSE: JNJ) announced a quarterly dividend increase from $1.30 to $1.34 per share, marking the 64th consecutive year of dividend increases. The dividend will be payable on June 9, 2026, to shareholders of record as of May 26, 2026. This represents a 3.08% increase over the prior quarterly dividend.
Current Dividend Yield and Income Impact
At yesterday’s closing price of $240.10, this increase raises JNJ’s forward dividend yield to approximately 2.23%.
As an owner of 60 shares of Johnson & Johnson, this dividend increase adds $7.15 to my projected annual net dividend income. I was expecting growth of around 4%, so this announcement came in as a slight disappointment.
Long-Term Dividend Growth Track Record
Johnson & Johnson is a Dividend Champion with a 63-year streak of dividend increases. According to Dividend Champions data, its dividend growth rates are:
- 1-year: 4.7%
- 3-year: 4.9%
- 5-year: 5.2%
- 10-year: 5.7%
This recent dividend increase marks the 12th consecutive raise I’ve received since initiating my position in February 2015. Over that time, the quarterly dividend has grown from $0.66 to $1.34 per share—an increase of approximately 103%, reflecting consistent long-term growth.
At the time of writing, JNJ represents about 1.46% of my portfolio and contributes approximately 0.84% of my projected annual dividend income. Following this increase, my yield on cost stands at 5.60%.
Quick Valuation Take
Johnson & Johnson appears fairly valued at current levels. As a diversified healthcare company with strong cash flow generation and a resilient business model, it remains a cornerstone holding for long-term investors.
Dividend Safety and Outlook
The dividend remains very well supported by consistent earnings and strong cash flows. Johnson & Johnson’s long-standing commitment to dividend growth and its defensive business profile suggest continued steady increases in the years ahead.
Final Thoughts
This was a slightly underwhelming increase compared to my expectations, but it continues Johnson & Johnson’s remarkable dividend growth streak. The company remains a dependable core holding in my portfolio, providing stability and reliable income growth.
Summary of 2026 Dividend Increases / Cuts
Click here to see my portfolio holdings
You can follow the development of my dividends here
Full Disclosure: Long JNJ
Thanks for stopping by!
No comments:
Post a Comment